Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,406.50
Bid: 1,405.00
Ask: 1,405.50
Change: -7.50 (-0.53%)
Spread: 0.50 (0.036%)
Open: 1,417.50
High: 1,418.50
Low: 1,386.50
Prev. Close: 1,414.00
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

17 Sep 2013 12:38

RNS Number : 2060O
Persimmon PLC
17 September 2013
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Persimmon PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

No

3. Full name of person(s) subject to thenotification obligation: iii

Ameriprise Financial, Inc and its group

4. Full name of shareholder(s)  (if different from 3.):iv

See additional information under 13.

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

12 September 2013

6. Date on which issuer notified:

16 September 2013

7. Threshold(s) that is/are crossed orreached: vi, vii

Below the threshold of 5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0006825383

15,321,191

15,321,191

207,602

207,602

14,209,167

0.068%

4.676%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

CFD

 

8,346

Nominal

Delta

0.003%

Total (A+B+C)

Number of voting rights

Percentage of voting rights

14,425,115

4.747%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Ameriprise Financial, Inc., which through intermediate holding companies controls the voting rights of Columbia Management Investment Advisers, Columbia Wanger Asset Management, Threadneedle Management Luxembourg S.A. and Threadneedle Asset Management Holdings Ltd, which itself controls the voting rights of Threadneedle Asset Management Ltd, Threadneedle International Ltd and Threadneedle Pensions Ltd.

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

Registered Owner

 

Littledown Nominees Ltd

 

A/c ZLA08

16,626

Royal Trust Corp of Canada

 

A/c 719306

201,133

The Bank of New York (Nominees) Limited

 

A/c PTG468

162,807

HSBC Global Custody Nominees (UK) Ltd

 

A/c 2456820

56,810

Littledown Nominees Ltd

 

A/c 76588

605,800

Harewood Nominees Ltd

A/c 1040411926G

2,513,837

HSBC Global Custody Nominee (UK) Ltd

 

A/c 740190

136,613

HSBC Global Custody Nominee (UK) Ltd

 

A/c 739874

652,389

HSBC Global Custody Nominee (UK) Ltd

 

A/c 740311

64,968

The Bank of New York (Nominees) Limited

 

A/c PTG 15303/09997799

73,907

The Bank of New York (Nominees) Limited

 

A/c 6252772001

8,346

HSBC Global Custody Nominee (UK) Ltd

 

A/c 811056

32,040

Nortrust Nominees LTD

 

A/c BBH05

102,941

Chase Nominees Limited

 

A/c 81587

357,747

William & Glyns (Isle of Man) Nominees Ltd

 

A/c 301780

37,135

Littledown Nominees Ltd

 

A/c ZLA03

4,322,634

The Bank of New York (Nominees) Limited

 

A/c 52266

414,418

Littledown Nominees Ltd

 

A/c 07198

186,967

Littledown Nominees Ltd

 

A/c 27642

20,635

Littledown Nominees Ltd

 

A/c ZLA09

8,643

Littledown Nominees Ltd

 

A/c 10479

6,667

Littledown Nominees Ltd

 

A/c ZLA12

204,589

Littledown Nominees Ltd

 

A/c ZLA14

54,855

Littledown Nominees Ltd

 

A/c 07207

332,757

Mellon Nominees (UK) Ltd

A/c WWSF0004002

189,923

Littledown Nominees Ltd

 

A/c 18668

374,207

Littledown Nominees Ltd

 

A/c 10491

1,182,066

Littledown Nominees Ltd

 

A/c 10488

970,590

Threadneedle Specialist Funds ICVC

A/c 34204

165,681

Littledown Nominees Ltd

 

A/c 31348

185,528

Littledown Nominees Ltd

 

A/c ZLA15

781,856

14. Contact name:

Stacey Dryburgh, Threadneedle Group

15. Contact telephone number:

01793 363751

 

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

Contact address

(registered office for legal entities)

 

Phone number & email

 

Other useful information

(at least legal representative for legal persons)

 

B: Identity of the notifier, if applicable

Full name

 

Contact address

 

Phone number & email

 

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFVLADIDLIV
Date   Source Headline
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company
10th Oct 20222:24 pmRNSDirector/PDMR Shareholding
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 20223:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.